Drug name - Safyral

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8617597 BAYER HLTHCARE Pharmaceutical composition containing a tetrahydrofolic acid Feb, 2030

(7 years from now)

More Information on Dosage
Strength Dosage Availability
3MG,N/A;0.03MG,N/A;0.451MG,0.451MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.